FIELD: medicine.
SUBSTANCE: by means of expression vector into plant cell introduced are nucleotide sequences, coding light and heavy chains of antibody, binding human VEGF. Antibody against human VEGF can be used, in particular, for reduction of microvascular permeability of human tumours and treatment of diabetic and age-related neovascular retinopathy.
EFFECT: antibody production in plant cells provides possibility of its obtaining in industrial scale, at a significantly lower cost than in obtaining in expression system on mammalian cell culture base, presence in obtained preparation of antibody of causative agents of prion, mycoplasmal and viral diseases of mammals is excluded.
39 cl, 11 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF HER2/neu ONCOGENE ANTIBODY SUPERPRODUCTION IN PLANT | 2007 |
|
RU2370280C2 |
METHOD OF OBTAINING THE ANTIBODY, WHICH SPECIFICALLY BINDS THE DOMAIN OF THE HER2/NEU EXCELLULAR PART OF THE HER2/NEU ONCOPROTEIN, IN THE PLANT, THE ANTIBODY, WHICH IS OBTAINED BY MEANS OF THIS METHOD AND ITS APPLICATION | 2016 |
|
RU2648161C2 |
HUMANIZED ANTI-VEGF MONOCLONAL ANTIBODY | 2020 |
|
RU2809746C2 |
BISPECIFIC BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES | 2011 |
|
RU2597973C2 |
ANTI-ROBO4 ANTIBODY | 2013 |
|
RU2682451C2 |
ANTI-VEGF ANTIBODIES AND APPLICATIONS THEREOF | 2010 |
|
RU2567639C2 |
ANTIBODY TO IL-13RA2 AND ITS APPLICATION | 2018 |
|
RU2756623C2 |
TRI- OR TETRASPECIFIC ANTIBODIES | 2010 |
|
RU2570633C2 |
BISPECIFIC ANTIBODIES | 2011 |
|
RU2573588C2 |
ANTIBODY FOR BLyS | 2013 |
|
RU2613422C2 |
Authors
Dates
2011-02-20—Published
2009-06-15—Filed